NWBO Earnings
Northwest Biotherapeutics, Inc.
1W: -6.2%
1M: -11.4%
3M: -20.1%
YTD: -41.1%
1Y: -39.7%
3Y: -81.9%
5Y: -89.7%
$0.15
-0.00 (-1.51%)
Weekly Expected Move ±5.5%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-08-14
EPS
$-0.01
▼ Miss +0.0%
Revenue
$807K
▲ Beat +0.0%
Next Earnings
2026-11-12
Revenue Estimate
$833K
Estimate vs Actual
Earnings Surprise History
0/18
EPS Beats
0/18
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | quarter | 2026-09-30 | $— | $— | — | $— | $832,727 |
| 2026-08-17 | quarter | 2026-06-30 | $— | $— | — | $509,748 | $807,000 |
| 2026-08-12 | quarter | 2019-06-30 | $— | $— | — | $— | $1,373,360,000 |
| 2026-08-12 | quarter | 2019-03-31 | $— | $— | — | $— | $1,373,360,000 |
| 2026-08-12 | annual | 2018-12-31 | $— | $— | — | $— | $1,373,360,000 |
| 2026-07-30 | quarter | 2026-06-30 | $— | $— | — | $— | $509,748 |
| 2026-05-21 | annual | 2027-12-31 | $— | $-0.07 | ▼ 0.07 | $— | $38,934,000 |
| 2026-04-16 | annual | 2026-12-31 | $-0.05 | $-0.05 | — | $1,609,252 | $1,562,308 |
| 2026-03-30 | annual | 2026-12-31 | $— | $-0.05 | ▼ 0.05 | $— | $1,609,252 |
Earnings Call Transcripts
No transcripts available.